A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia

BACKGROUND: Iron deficiency anaemia is common in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and is often treated with oral or intravenous (IV) iron therapy. This trial compared the efficacy and safety of IV iron isomaltoside 1000 (Monofer®) and oral iron in NDD-CKD patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Philip A., Bhandari, Sunil, Saxena, Sanjiv, Agarwal, Dhananjai, Wirtz, Georg, Kletzmayr, Josef, Thomsen, Lars L., Coyne, Daniel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
CLINICAL SCIENCE
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805129/
https://www.ncbi.nlm.nih.gov/pubmed/26250435
http://dx.doi.org/10.1093/ndt/gfv293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805129/
https://www.ncbi.nlm.nih.gov/pubmed/26250435
http://dx.doi.org/10.1093/ndt/gfv293

Ejemplares similares